Inventor · disambiguated record
James J. Perkins
Also filed as: PERKINS JAMES J
32 granted patents·10 pending applications·422 citations·filing 1993–2024
97Inventor score
Files withMERCK & CO INC22MERCK SHARP & DOHME7MERCK SHARP & DOHME LLC6MEISSNER ROBERT S3BUNGARD CHRISTOPHER J1
Top patents by PatentIndex Score
42 records- 0193US6066648AIntegrin receptor antagonistsMERCK & CO INC·Filed 1998·Granted May 23, 2000·67 cites·40 claims
- 0291US11377438B22-amino-n-heteroaryl-nicotinamides as Nav1.8 inhibitorsMERCK SHARP & DOHME·Filed 2019·Granted Jul 5, 2022·6 cites·22 claims
- 0390US6410526B1αv integrin receptor antagonistsMERCK & CO INC·Filed 2000·Granted Jun 25, 2002·40 cites·28 claims
- 0490US6358970B1Integrin receptor antagonistsMERCK & CO INC·Filed 2000·Granted Mar 19, 2002·41 cites·19 claims
- 0590US6268378B1Integrin receptor antagonistsMERCK & CO INC·Filed 2000·Granted Jul 31, 2001·28 cites·30 claims
- 0688US7268153B2N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulatorsMERCK & CO INC·Filed 2005·Granted Sep 11, 2007·14 cites·13 claims
- 0786US7365202B2Polymorphs of an androgen receptor modulatorMERCK & CO INC·Filed 2006·Granted Apr 29, 2008·11 cites·31 claims
- 0883US6472403B2αV integrin receptor antagonistsMERCK & CO INC·Filed 2001·Granted Oct 29, 2002·20 cites·14 claims
- 0981US9278960B2Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their useMERCK SHARP & DOHME·Filed 2012·Granted Mar 8, 2016·4 cites·21 claims
- 1081US7625920B2Fluorinated 4-azasteroid derivatives as androgen receptor modulatorsMERCK & CO INC·Filed 2008·Granted Dec 1, 2009·2 cites·7 claims
- 1181US7186838B2Fluorinated 4-azasteroid derivatives as androgen receptor modulatorsMERCK & CO INC·Filed 2003·Granted Mar 6, 2007·16 cites·25 claims
- 1281US5648368AFibrinogen receptor antagonistsMERCK & CO INC·Filed 1993·Granted Jul 15, 1997·49 cites·13 claims
- 1380US2025084064A12-amino-n-heteroaryl-nicotinamides as nav1.8 inhibitorsMERCK SHARP & DOHME LLC·Filed 2024·Application pending·0 cites
- 1478US7153862B2αv integrin receptor antagonistsMERCK & CO INC·Filed 2003·Granted Dec 26, 2006·10 cites·5 claims
- 1576US9663506B2Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their useMERCK SHARP & DOHME·Filed 2016·Granted May 30, 2017·2 cites·16 claims
- 1676US9636337B2Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their useMERCK SHARP & DOHME·Filed 2016·Granted May 2, 2017·2 cites·30 claims
- 1775US6211184B1Integrin antagonistsMERCK & CO INC·Filed 1997·Granted Apr 3, 2001·21 cites·16 claims
- 1874US5981546AIntegrin antagonistsMERCK & CO INC·Filed 1997·Granted Nov 9, 1999·45 cites·17 claims
- 1973US5780480AFibrinogen receptor antagonistsMERCK & CO INC·Filed 1997·Granted Jul 14, 1998·17 cites·11 claims
- 2072US12195445B22-amino-N-heteroaryl-nicotinamides as Nav1.8 inhibitorsMERCK SHARP & DOHME LLC·Filed 2022·Granted Jan 14, 2025·0 cites·15 claims
- 2172US7629367B2N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulatorsMERCK & CO INC·Filed 2005·Granted Dec 8, 2009·1 cites·1 claims
- 2270US6693101B2αv integrin receptor antagonistsMERCK & CO INC·Filed 2001·Granted Feb 17, 2004·4 cites·1 claims
- 2370US2023312528A12-oxo-imidazolidine-4-carboxamides as nav1.8 inhibitorsMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 2467US10072003B2Tetrahydronaphthyridine derivatives as mGluR2-negative allosteric modulators, compositions, and their useMERCK SHARP & DOHME·Filed 2015·Granted Sep 11, 2018·1 cites·8 claims
- 2562US11802122B22-oxoimidazolidine-4-carboxamides as NAv1.8 inhibitorsMERCK SHARP & DOHME·Filed 2021·Granted Oct 31, 2023·0 cites·46 claims
- 2660US7763659B2N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulatorsMERCK SHARP & DOHME·Filed 2007·Granted Jul 27, 2010·0 cites·1 claims
- 2759US6211191B1Integrin receptor antagonistsMERCK & CO INC·Filed 1998·Granted Apr 3, 2001·16 cites·23 claims
- 2859US2025223259A1Protease inhibitors for treating or preventing coronavirus infectionMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 2958US7351698B2Androgen receptor modulators and methods of use thereofMERCK & CO INC·Filed 2004·Granted Apr 1, 2008·0 cites·1 claims
- 3058US2007088042A1Fluorinated 4-azasteroid derivatives as androgen receptor modulatorsMEISSNER ROBERT S·Filed 2006·Application pending·0 cites
- 3157US2008119503A1Androgen receptor modulators and methods of use thereofMEISSNER ROBERT S·Filed 2008·Application pending·0 cites
- 3253US12246008B24-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activity in voltage-gated sodium channelsMERCK SHARP & DOHME LLC·Filed 2019·Granted Mar 11, 2025·0 cites·17 claims
- 3351US5952306AIntegrin receptor antagonistsMERCK & CO INC·Filed 1997·Granted Sep 14, 1999·5 cites·8 claims
- 3447US2009275515A12-hydroxy-2-phenylthiophenylpropionamides as androgen receptor modulatorsKIM YUNTAE·Filed 2007·Application pending·0 cites
- 3544US12344595B22-amino-n-phenyl-nicotinamides as NAV1.8 inhibitorsMERCK SHARP & DOHME LLC·Filed 2019·Granted Jul 1, 2025·0 cites·15 claims
- 3644US7410977B2Fluorinated 4-azasteroids as androgen receptor modulatorsMERCK & CO INC·Filed 2005·Granted Aug 12, 2008·0 cites·6 claims
- 3743US7605152B217-hydroxy-4-aza-androstan-3-ones as androgen receptor modulatorsMERCK & CO INC·Filed 2003·Granted Oct 20, 2009·0 cites·11 claims
- 3842US2008124402A1N-(Pyridin-3-Yl)-2-Phenylbutanamides As Androgen Receptor ModulatorsMERCK & CO INC·Filed 2005·Application pending·0 cites
- 3942US2009088458A1N-(Pyridin-4-Yl)-2-Phenylbutanamides as Androgen Receptor ModulatorsMEISSNER ROBERT S·Filed 2006·Application pending·0 cites
- 4039US8119681B22-[1-phenyl-5-hydroxy or methoxy-4alpha-methyl-hexahydrocyclopenta [ƒ]indazole-5-YL]ethyl phenyl derivatives as glucocorticoid receptor ligandsBUNGARD CHRISTOPHER J·Filed 2007·Granted Feb 21, 2012·0 cites·17 claims
- 4137US2010267633A1N-(4-Oxo-3,4-Dihydroquinazolin-2Yl) Butanamides as Androgen Receptor ModulatorsHANNEY BARBARA·Filed 2006·Application pending·0 cites
- 4233US2012214847A12-[1-PHENYL-5-HYDROXY-4a-SUBSTITUTED-HEXAHYDROCYCLOPENTA[F]INDAZOL-5-YL]ETHYL PHENYL DERIVATIVES AS GLUCOCORTICOID RECEPTOR LIGANDSBUNGARD CHRISTOPHER JAMES·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when James J. Perkins files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →